Variant position: 222 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 267 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LEALKENGGARLAEYHAKAT EHLSTLSEKAKPALEDLRQGL
Gorilla LEALKENGGARLAEYHAKAT EHLSTLSEKAKPALEDLRQGL
Rhesus macaque LEALKENGGARLAEYHAKAS EHLSTLSEKAKPALEDLRQGL
Chimpanzee LEALKENGGARLAEYHAKAT EHLSTLSEKAKPALEDLRQGL
Mouse LAELKSN--PTLNEYHTRAK THLKTLGEKARPALEDLRHSL
Rat LTEIKNH--PTLIEYHTKAS DHLKTLGEKAKPALDDLGQGL
Pig FEALKEGGGS-LAEYQAKAQ EQLKALGEKAKPALEDLRQGL
Bovine LEALKEGGGS-LAEYHAKAS EQLKALGEKAKPVLEDLRQGL
Rabbit LESIKEGGGASLAEYQAKAR EHLSVLSEKARPALEDLRQGL
Chicken LEEIREKGIPQASEYQAKVM EQLSNLREKMTPLVQEFRERL
Zebrafish LEDLRTMAAPYAEEYKEQLV KAVEEAREKIAPHTQDLQTRM
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
19 – 267 Proapolipoprotein A-I
25 – 267 Apolipoprotein A-I
25 – 266 Truncated apolipoprotein A-I
211 – 232 8
68 – 267 10 X approximate tandem repeats
Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.
von Eckardstein A.; Funke H.; Walter M.; Altland K.; Benninghoven A.; Assmann G.;
J. Biol. Chem. 265:8610-8617(1990)
Cited for: VARIANTS GLU-113; MET-131; GLY-163; VAL-171 AND LYS-222;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.